FDA Inspection 1199227 — Vitalant
The FDA completed an inspection of Vitalant on February 23, 2023 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lubbock, TX (United States)